Magnesium salts of 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanopro staglandins
US4035360A · kind A · utility
5Cited by
4References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 1975 |
| Grant date | Jul 12, 1977 |
| Priority date | — |
| Expiry date | Dec 22, 1995 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6524
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The magnesium salts of 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorpr ostaglandins are disclosed. The novel prostaglandin salt of this invention have been found to have activity profiles comparable to the parent prostaglandins, but exhibit a greater tissue specificity of action and are further valuable because they are crystalline and thus may be easily isolated, purified and compounded into medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.